This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Novozymes Biopolymer A/s. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Fanny Longin: Innovator in Hyaluronic Acid Cross-Linking
Introduction
Fanny Longin is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of biopolymers, particularly through his innovative methods involving hyaluronic acid.
Latest Patents
Fanny Longin holds a patent for a method of cross-linking hyaluronic acid with divinylsulfone. This invention relates to producing a homogenous hydrogel that comprises hyaluronic acid, or its salt, crosslinked with divinylsulfone (DVS). The method includes several steps: providing an alkaline solution of hyaluronic acid; adding DVS to this solution, which results in the crosslinking of hyaluronic acid with DVS to form a gel; and treating the gel with a buffer to swell and form a hydrogel.
Career Highlights
Throughout his career, Fanny Longin has worked with prominent companies in the biopolymer sector, including Novozymes Biopolymer A/S and Albumedix A/S. His work has contributed to advancements in the production and application of biopolymers.
Collaborations
Fanny Longin has collaborated with professionals such as Khadija Schwach-Abdellaoui, enhancing the research and development in his field.
Conclusion
Fanny Longin's innovative work in cross-linking hyaluronic acid has paved the way for advancements in hydrogel technology. His contributions to the industry reflect his commitment to innovation and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile